Tinidazole

Drug Profile

Tinidazole

Alternative Names: Tindamax

Latest Information Update: 07 Apr 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Presutti Laboratories LLC
  • Developer Mission Pharmacal
  • Class Antibacterials; Antiprotozoals; Nitroimidazoles
  • Mechanism of Action DNA synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Amoebiasis; Amoebic liver abscess; Giardiasis; Trichomoniasis
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Amoebiasis; Amoebic liver abscess; Bacterial vaginosis; Giardiasis; Trichomoniasis

Most Recent Events

  • 24 May 2007 Registered for Bacterial vaginosis in USA (PO)
  • 17 Aug 2006 Preregistration for Bacterial vaginosis in USA (PO)
  • 17 Aug 2006 Mission Pharmacal has filed a sNDA for a new indication - the treatment of patients with Bacterial vaginosis in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top